Comparative analysis of titers of antibody against measles virus in sera of vaccinated and naturally infected Japanese individuals of different age groups

Journal of Clinical Microbiology

Volumn 40, Issue 5, 2002, Pages 1733-1738

  Itoh, Masae ^a   Okuno, Yoshinobu ^a   Hotta, Hak ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES VACCINE; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIBODY TITER; ANTIGENICITY; ARTICLE; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GROUPS BY AGE; HEMAGGLUTINATION INHIBITION; HUMAN; IMMUNITY; INFANT; JAPAN; MAJOR CLINICAL STUDY; MALE; MEASLES; MEASLES VIRUS; NONHUMAN; PRIORITY JOURNAL; VACCINATION; VIRUS STRAIN;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; ANTIBODY FORMATION; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; JAPAN; MEASLES; MEASLES VACCINE; MEASLES VIRUS; MIDDLE AGED;

MEASLES VIRUS; RNA VIRUSES;

EID: 0036247238     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.40.5.1733-1738.2002     Document Type: Article

References (34)

1. Identification of an immunodominant neutralizing and protective epitope from measles virus fusion protein by using human sera from acute infection
2. Booster vaccination with further live attenuated measles vaccine
3. Measles - United States 1993
4. Progress toward interrupting indigenous measles transmission-region of the Americas, January 1999-September 2000
5. Measles, rubella, and congenital rubella syndrome-United States and Mexico 1997-1999
6. Notice to readers: Recommendation from meeting on strategies for improving global measles control, May 11-12, 2000
7. Estimated susceptibility to asymptomatic secondary immune response against measles in late convalescent and vaccinated persons
8. Characterization of a natural mutation in an antigenic site on the fusion protein of measles virus that is involved in neutralization
9. Immune responses to measles and mumps vaccination of infants at 6, 9, and 12 months
10. Measles, Japan 1999-2001
11. Molecular epidemiology and changing distribution of genotypes of measles virus field strains in Japan
12. Resistance of recent measles virus wild-type isolates to antibody-mediated neutralization by vaccinees with antibody
13. Marmoset lymphoblastoid cells as a sensitive host for isolation of measles virus
14. Nonhuman primate models of measles
15. Immune response to measles vaccine in 6-month-old infants of measles seronegative mothers
16. The role of secondary vaccine failures in measles outbreaks
17. Reduced passive measles immunity in infants of mothers who have not been exposed to measles outbreaks
18. Disease eradication as a public health strategy: Is measles next?
19. Temporal and geographical distribution of measles virus genotypes
20. Molecular epidemiology of measles virus: Identification of pathways of transmission and implications for measles elimination
21. Variation in field isolates of measles virus during an 8-year period in Japan
22. Measles virus in the CNS: The role of viral and host factors for the establishment and maintenance of a persistent infection
23. Increased binding activity of measles virus to monkey red blood cells after long-term passage in Vero cell cultures
24. Impact of revaccinating children who initially received measles vaccine before 10 months of age
25. Single genotype of measles virus is dominant whereas several genotypes of mumps virus are co-circulating
26. The genome nucleotide sequence of a contemporary wild strain of measles virus and its comparison with the classical Edmonston strain genome
27. Antigenic analysis of current wild type and vaccine strains of measles virus
28. The hemagglutinin of recent measles virus isolates induces cell fusion in a marmoset cell line, but not in other CD46-positive human and monkey cell lines, when expressed together with the F protein
29. Subacute sclerosing panencephalitis
30. Seroepidemiological study on prevalence of measles antibodies in Urawa city
31. Viral replication and development of specific immunity in macaques after infection with different measles virus strains
32. Measurement of measles virus-specific neutralizing antibodies: Evaluation of the syncytium inhibition assay in comparison with the plaque reduction neutralization test
33. Expanded programme on immunization. Standardization of the nomenclature for describing the genetic characteristics of wild-type measles viruses
34. Identification of three lineages of wild measles virus by nucleotide sequence analysis of N, P, M, F, and L genes in Japan